Evidence map›Paper›PMID 29881456›Full record

ReviewBiotechnology for biofuels2018

Recent advances in bio-based multi-products of agricultural Jerusalem artichoke resources.

Yibin Qiu, Peng Lei, Yatao Zhang, Yuanyuan Sha, Yijing Zhan, Zongqi Xu, Sha Li, Hong Xu, Pingkai Ouyang

Abstract readReview
In one paragraph

Review in Biotechnology for biofuels, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Optimization of Inulin Hydrolysis byFrontiers in bioengineering and biotechnology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Systematic unravelling of the inulin hydrolase fromBiotechnology for biofuels · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yibin Qiu *1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.
Peng Lei *Nanjing Institute for Comprehensive Utilization of Wild Plants, Nanjing, 210042 China.
Yatao Zhang1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.
Yuanyuan Sha1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.
Yijing Zhan1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.
Zongqi Xu3Jiangsu National Synergetic Innovation Center for Advanced Materials, Nanjing Tech University, Nanjing, 211816 China.
Sha Li1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.
Hong Xu1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.ORCID 0000-0003-0601-6321
Pingkai Ouyang1College of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Jerusalem artichoke is a perennial plant that belongs to the sunflower family. As a non-grain crop, Jerusalem artichoke possesses a number of desirable characteristics that make it a valuable feedstock for biorefinery, such as inulin content, rapid growth, strong adaptability, and high yields. This review provides a comprehensive introduction to renewable Jerusalem artichoke-based biomass resources and recent advances in bio-based product conversion. Furthermore, we discuss the latest in the development of inulinase-producing microorganisms and enhanced inulin hydrolysis capacity of microbes by genetic engineering, which lead to a more cost-effective Jerusalem artichoke biorefinery. The review is aimed at promoting Jerusalem artichoke industry and new prospects for higher value-added production.

Indexed as

BiorefineryInulinInulinaseJerusalem artichokeNon-grain fermentation

Identifiers

PMID29881456
PMCPMC5984348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.